Home
About Us
Company Profile
Boards & Staffs
Memberships & Partners
Academy of Journalism
Careers
Blog(EN)
Contact Us
Journals
Our Journals
Instruction for Authors
Brieflands Policies
Publish My Research
Journal Management System
Article Processing Charges
Open Peer Review
Publishing Services
Books
Publish My Book
Brieflands
journals
IJ Pharmaceutical Research
Articles
Insulin and TLR4 Inhibitor Improve Motor Impairments in a Rat Model of Parkinson’s Disease
Scopus by Title (Ref)
IJ Pharmaceutical Research
Home
Archives
Current Issue
All Issues
In Press
Accepted Manuscripts
Search
Instructions
About Journal
Journal Information
Editors & Boards
Indexing and Listing Sources
Journal Metrics
Open Peer Review (OPR)
Publication Ethics and Malpractice Statement
Reviewer and AE Registration Form
Support
Contact Us
APC
Authors Guide
Submit Manuscript
Scopus by Title (Ref)
1. Potentials of cepharanthine and tomatidine as novel LpxC and TLR4 inhibitors to mitigate gut-mediated inflammation in Parkinson’s disease: a high-throughput investigation through molecular docking and dynamic simulation
- Roy R. , et al.